BioNTech Q1 Net Loss Widens; Backs FY26 Revenue Outlook
5/5 13:36
(RTTNews) - Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Tuesday a net loss of 531.9 million euros or 2.10 euros per share for the first quarter, wider than 415.8 million euros or 1.73 euros per share in the prior-year quarter....